Table 5 Demographic and clinical characteristics of early and middle-advanced PD patients
Variable | Early (n = 30) | Mid-advanced (n = 40) | p value |
|---|---|---|---|
Age, years | 61.60(9.58) | 68.30(7.12) | 0.002 |
Male/female ratio | 16/14 | 25/15 | 0.441 |
Disease duration, years | 5.28(3.46) | 8.58(3.72) | 0.000 |
MDS-UPDRS III “off” (0-132) | 38.97(15.70) | 56.43(17.24) | 0.000 |
WBC, 10^9/L | 5.51(1.79) | 6.52(2.21) | 0.026 |
Neutrophils (%) | 57.89(10.40) | 65.57(10.20) | 0.003 |
Lymphocyte (%) | 33.34(9.51) | 25.99(8.60) | 0.001 |
Monocytes (%) | 6.71(2.68) | 5.81(1.57) | 0.146 |
N/L | 2.41(3.47) | 3.21(2.46) | 0.002 |
M/L | 0.24(0.20) | 0.24(0.08) | 0.031 |
RBC, 10^12/L | 4.38(0.48) | 4.37(0.49) | 0.927 |
Hb, g/L | 133.27(14.68) | 134.5(13.59) | 0.718 |
Hct, L/L | 0.400(0.041) | 0.403(0.039) | 0.739 |